Janos Szebeni
Group Head at the Department of Translational Medicine Semmelweis University
Janos Szebeni is Group Head at Semmelweis University and a leading expert in nanomedicine and immunotoxicology. With 40+ years’ experience, he pioneered the CARPA concept, authored 200+ publications, and specializes in predicting and mitigating immune responses to nanoparticle-based therapies.
Seminars
Thursday 24th September 2026
mRNA–LNP COVID-19 Vaccines: Insights from Conventional Immunisation & Drug-Targeting Principles
2:00 pm
- Applying drug-targeting and immunisation principles to reduce off-target toxicity and improve tolerability of mRNA–LNP vaccines
- Designing formulations and dosing strategies that enable safe repeat administration without diminishing immune response
- Optimising LNP composition and delivery to enhance therapeutic durability and sustain protective efficacy over time
